The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
If so, perhaps you can join the TRITON Study and possibly help find better treatment options for future sufferers of COPD.
Study participation is at no charge, and compensation for time and travel expenses may be available to those who satisfy applicable requirements.
To join the TRITON Study, potential participants must:
- Be a current or ex-smoker at least 40 years of age
- Have been diagnosed with COPD for at least one year
- Require daily medication to control their COPD symptoms
Other requirements may apply.
To learn more about the TRITON Study, a medical research study of an investigational medication for those who suffer from COPD, please contact us today 786-772-0510
Learn about a local study testing a potential new treatment
Indago Research in Hialeah is conducting a clinical study to evaluate a potential new treatment for Chronic Obstructive Pulmonary Disease (COPD) for those experiencing flare-ups.
Participants are needed to help learn more about a potential new treatment option.
Do You Qualify?
We’re seeking the following people to participate in this study:
- Aged 40 years or older
- Have COPD with occasional flare-ups requiring treatment
- Currently prescribed daily inhaled maintenance therapy, with a stable dose for at least 3 months for COPD
- Be a current or former smoker who quit 6 or more months before entering the study
- Have had at least one COPD exacerbation in the past 12 months
There’s no cost to participate in this study, no placebo, and you do not need health insurance. Reimbursement for reasonable expenses such as travel may also be available for qualified participants.
Learn More
To find out if you or a loved one are eligible for this study, please contact us at 786-772-0510.
Getting to the heart of cardiovascular disease
The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
If you are interested in taking part in the VICTORION-2 PREVENT Study, we’re searching for people who:
· Are 40 years of age and older
· Have previously experienced a heart attack, stroke or reduced blood flow to limbs caused by narrowed arteries (peripheral arterial disease)
· Are currently receiving a high-intensity statin (medication that lowers the level of harmful cholesterol in the blood)
There are other criteria that you will need to meet to qualify for participation in this study, which the study team can discuss with you.
For further information about the VICTORION-2 PREVENT Study, visit www.V2PSTUDY.com or contact:
786-772-0510
Researchers are conducting a new clinical research study designed to see if an investigational drug helps reduce the risk of future cardiovascular events, such as heart attacks and strokes.
The SURMOUNT-MMO Study is evaluating the effectiveness of an investigational medication (trial treatment) on reducing health risks that are commonly found in people who are living with obesity or are overweight. This clinical trial is focusing particularly on cardiovascular (heart) disease and other heart health risks.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)